PMID- 33100105
OWN - NLM
STAT- MEDLINE
DCOM- 20210624
LR  - 20210624
IS  - 1532-2491 (Electronic)
IS  - 1082-6084 (Linking)
VI  - 56
IP  - 1
DP  - 2021
TI  - MDMA Use by Paris Medical Students: Prevalence and Characteristics.
PG  - 67-71
LID - 10.1080/10826084.2020.1837167 [doi]
AB  - 3,4-Methylenedioxy-N-methylamphetamine (MDMA) is increasing being used by youth 
      in Europe and in France, but characteristics of its use are unknown. Objectives: 
      The aim was to characterize MDMA use in a sample of French medical students. 
      Methods: Cross-sectional study of Paris VII medical students (N = 592) with an 
      online self-reporting questionnaire. Results: 592 students completed the online 
      questionnaire. 21.5% (n = 127) had experimented with MDMA. Use of MDMA was 
      associated with male sex (p < 0.001), older age (p < 0.001), left the parent's 
      home (p < 0.01), and belonging to a fraternity (p < 0.05). Most experimenters 
      (90.7%) used MDMA in a club or during a music festival. Among users, 42.5% used 
      it more than once a year and less than once a month. During the use, users drank 
      alcohol (90.6%), smoked tobacco (70.9%), smoked cannabis (42.0%) or used cocaine 
      (20.5%). In the days after the use, some smoked tobacco (40.9%), smoked cannabis 
      (29.1%), drank alcohol (22.0%), used cocaine (1.6%) and also took benzodiazepines 
      (5.5%). According to the Diagnostic and Statistical Manual of Mental Disorders, 
      5th Edition, criteria, the prevalence of MDMA use disorder was 8.5% in our sample 
      and 40.9% among MDMA users. As compared with students who never experienced MDMA, 
      fewer users thought that occasional intake could be dangerous (66.9% vs 83.9%, 
      p < 0.001) and that MDMA could be addictive (74.0% vs 90.3%, p < 0.001). 
      Conclusions: Other studies focusing on drug consumption among students are 
      necessary to define specific public health strategies of prevention and harmful 
      reduction.
FAU - Bazin, Balthazar
AU  - Bazin B
AD  - Department of Psychiatry and Addictive Medicine, Hopital Bichat-Claude Bernard, 
      Assistance Publique des Hopitaux de Paris, Paris, France.
FAU - Duroy, David
AU  - Duroy D
AD  - Department of Psychiatry and Addictive Medicine, Hopital Bichat-Claude Bernard, 
      Assistance Publique des Hopitaux de Paris, Paris, France.
FAU - Lejoyeux, Michel
AU  - Lejoyeux M
AD  - Department of Psychiatry and Addictive Medicine, Hopital Bichat-Claude Bernard, 
      Assistance Publique des Hopitaux de Paris, Paris, France.
AD  - Paris Diderot University- Paris VII, Paris, France.
LA  - eng
PT  - Journal Article
DEP - 20201024
PL  - England
TA  - Subst Use Misuse
JT  - Substance use & misuse
JID - 9602153
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - Adolescent
MH  - Aged
MH  - Cross-Sectional Studies
MH  - Europe
MH  - France/epidemiology
MH  - Humans
MH  - Male
MH  - *N-Methyl-3,4-methylenedioxyamphetamine
MH  - Prevalence
MH  - *Students, Medical
MH  - *Substance-Related Disorders/epidemiology
OTO - NOTNLM
OT  - 3,4-Methylenedioxymethamphetamine
OT  - MDMA use
OT  - MDMA use disorder
OT  - Medical students
OT  - epidemiology
EDAT- 2020/10/27 06:00
MHDA- 2021/06/25 06:00
CRDT- 2020/10/26 05:17
PHST- 2020/10/27 06:00 [pubmed]
PHST- 2021/06/25 06:00 [medline]
PHST- 2020/10/26 05:17 [entrez]
AID - 10.1080/10826084.2020.1837167 [doi]
PST - ppublish
SO  - Subst Use Misuse. 2021;56(1):67-71. doi: 10.1080/10826084.2020.1837167. Epub 2020 
      Oct 24.